Our Science • Our science stories • Detail

UCB Stories

Collaborating with Microsoft to reinvent how medicines are made

Posted by Herman De Prins, Information Technology 02-Mar-2021

Read more
Like
Tiny antibodies could have big potential

Posted by Scott Fleming, Global Communications & Company Reputation 05-Oct-2020

Read more
Like
COVID-19: How AI partnership is helping our search for new therapies

Posted by Erica Puntel, US Corporate Affairs 23-Sep-2020

Read more
Like
Getting personal: improving the lives of people with skin diseases

Posted by Matladi Ndlovu, Patient Value Unit - Immunology 24-Apr-2019

Read more
Like
New approach accelerates drug discovery

Posted by Rafal Kaminski, Patient Value Unit - New Medicines 05-Sep-2018

Read more
Like
Celebrating 10 years of innovating together

Posted by Katharina Klapper, Public-Private Partnerships Europe 04-Jul-2018

Read more
Like
UCB partners with UK scientists on antibody discovery initiative

Posted by Ross Carroll, Government Affairs & Market Access 04-Aug-2017

Read more
Like
Signalling our commitment to partnership

Posted by Florence Lebon, Discovery Chemistry, New Medicines 18-Apr-2017

Read more
Like
Exploring the "treasure trove" of gut bacteria

Posted by Ray Jupp,Patient Value Unit - New Medicines 20-Mar-2017

Read more
Like
Unlocking the secrets of epilepsy genetics

Posted by Rafal Kaminski, Patient Value Unit - New Medicines 25-Jan-2016

What are the genetic factors behind epilepsy and how does it develop?...

Read more
Like

Our Company